| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BO Brian Oliveira Clear Street Group Inc. | 12,019 | $17,668 | $5,408.55 | -$12,259.45 | -69.39% |
| Pharmaceuticals Industry | Healthcare Sector | Chenyu Liang CEO | NASDAQ (CM) Exchange | G6365B104 CUSIP |
| HK Country | 27 Employees | - Last Dividend | - Last Split | - IPO Date |
Cellyan Biotechnology Co., Ltd is an investment holding company that operates specifically within the over-the-counter (OTC) pharmaceutical sector, predominantly in Hong Kong and Mainland China. The company specializes in the procurement and distribution of OTC pharmaceuticals, utilizing both traditional and e-commerce platforms to optimize its operations. Cellyan Biotechnology also provides essential logistical services, including custom clearance and support for drugs enlisting, thereby facilitating a smooth supply chain for its partners. Established in 2023, and with a recent name change from Hong Kong Pharma Digital Technology Holdings Limited in December 2025, the company is strategically headquartered in Yau Tong, Hong Kong, to cater to the burgeoning pharmaceutical and e-commerce landscapes in the region.
Cellyan Biotechnology engages in the cross-border procurement of over-the-counter pharmaceuticals. This service ensures that high-quality medicinal products are readily available for distribution within Hong Kong and Mainland China, catering to the needs of consumers and health professionals alike.
The company provides robust distribution services tailored for the OTC pharmaceutical market. This includes a network designed to reach various stakeholders, such as e-commerce platforms, merchants, and pharmaceutical distributors, ensuring timely and efficient delivery of products.
Cellyan Biotechnology offers comprehensive e-commerce supply chain solutions designed for pharmaceutical products. This service encompasses logistics management specific to online sales, facilitating seamless transactions between suppliers and customers in the digital marketplace.
To navigate the complexities of cross-border trade, Cellyan Biotechnology provides custom clearance services. This ensures that all imported OTC products comply with local regulations, thus expediting the entry of goods into the marketplace.
The company also assists in the drugs enlisting process, helping pharmaceutical products gain official approval for sale in Hong Kong and Mainland China. This is an essential service that supports regulatory compliance and the safe introduction of new products.
Cellyan Biotechnology offers effective warehouse management solutions to ensure proper storage and handling of OTC pharmaceuticals. This service includes maintaining optimal inventory levels and ensuring the conditions meet regulatory standards for drug storage.
In addition to its other services, Cellyan provides a range of logistics services aimed at streamlining operations within the pharmaceutical supply chain. This includes transportation, inventory management, and distribution planning tailored for the specific needs of its partners.